Global Anatomic Pathology Testing Market 2017-2021


#1027806

95pages

Technavio

$ 3500

In Stock

About Anatomic Pathology Testing

The anatomic pathology testing helps in identifying abnormalities in tissue or cell lines and develops personalized care treatment. It helps to evaluate different types of cancers such as lung cancer, breast cancer, colorectal cancer, and chronic conditions such as kidney or liver disease, infectious disease, and autoimmune diseases.

Technavios analysts forecast the global anatomy pathology testing market to grow at a CAGR of 8.26% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global anatomy pathology testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from anatomy pathology testing.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Anatomic Pathology Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Diagnostics
Agilent Technologies
Danaher
Roche Diagnostics
Thermo Fisher Scientific

Other prominent vendors
20/20 GeneSystems
Abcam
AdnaGen
Advanced Cell Diagnostics
Agendia
Angsana Molecular & Diagnostics Laboratory
AutoGenomics
Biocare Medical
Biocartis
CellMax Life
Cancer Genetics
Digipath
Enzo Biochem
Epic Sciences
Janssen Diagnostic
Monogram Biosciences
Nucleix
Omnyx
Oxford Cancer Biomarkers
RareCyte
SAKURA FINETEK USA
Tecan
VolitionRx

Market driver
Growing prevalence of cancer in demographics
For a full, detailed list, view our report

Market challenge
High initial investment and maintenance costs
For a full, detailed list, view our report

Market trend
Presence of venture capitalists in market
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.




Table of Contents

PART 01: Executive summary

PART 02: Scope of the report


Market overview
Top-vendor offerings


PART 03: Market research methodology


Research methodology
Economic indicators


PART 04: Introduction


Key market highlights


PART 05: Market landscape


Market overview
Market size and forecast
Five forces analysis


PART 06: Market segmentation by products


Instruments and imaging systems
Consumables and accessories


PART 07: Market segmentation by application


Breast cancer
Lung cancer
Colorectal cancer
Lymphoma
Cervical cancer
Prostate cancer
Other diseases


PART 08: Market segmentation by end-user


Hospitals
Clinical diagnostic laboratories
Physicians office laboratories


PART 09: Geographical segmentation


Anatomic pathology testing market in Americas
Anatomic pathology testing market in EMEA
Anatomic pathology testing market in APAC


PART 10: Market drivers


Growing prevalence of cancer in demographics
Use of biomarkers for disease diagnosis and increasing efficiency
Paradigm shift toward precision diagnosis through personalized medicine


PART 11: Impact of drivers

PART 12: Market challenges


Insurance coverage and reimbursement issues
Limitations of closed systems
High initial investment and maintenance cost


PART 13: Impact of drivers and challenges

PART 14: Market trends


Presence of venture capitalists in market
Ready-to-use reagents
Business strategies to increase market competitiveness


PART 15: Vendor landscape


Competitive landscape analysis


PART 16: Key vendor analysis


Abbott Diagnostics
Agilent Technologies
Danaher
Roche Diagnostics
Thermo Fisher Scientific
Other prominent vendors


PART 17: Appendix


List of abbreviations


PART 18: Explore Technavio
List of Exhibits

Exhibit 01: Product offerings

Exhibit 02: Methods used in anatomic pathology testing

Exhibit 03: Use of digital pathology testing

Exhibit 04: Global anatomic pathology testing market 2016-2021 ($ millions)

Exhibit 05: Product dynamic analysis of instruments and reagents in 2016 and 2021

Exhibit 06: Five forces analysis

Exhibit 07: Global anatomic pathology testing market by products in 2016 and 2021 ($ billions)

Exhibit 08: Market overview: Instruments and imaging systems

Exhibit 09: Anatomic pathology testing market by instruments and imaging systems 2016-2021 ($ billions)

Exhibit 10: Market overview: Consumables and accessories

Exhibit 11: Anatomic pathology testing market by consumables and accessories 2016-2021 ($millions)

Exhibit 12: Global anatomic pathology testing market by application in 2016

Exhibit 13: Global anatomic pathology testing market by end-users in 2015

Exhibit 14: Strategies, benefits and challenges of clinical diagnostic laboratories to remain competitive

Exhibit 15: Global anatomic pathology testing market by geography in 2016 and 2021 ($billions)

Exhibit 16: Market overview: Anatomic pathology testing market in Americas

Exhibit 17: Anatomic pathology testing market in Americas 2016-2021 ($ billions)

Exhibit 18: Key takeaway: Anatomic pathology testing market in US

Exhibit 19: PEST analysis: Anatomic pathology testing market in UK

Exhibit 20: Market overview: Anatomic pathology testing market in EMEA

Exhibit 21: Anatomic pathology testing market in EMEA 2016-2021 ($billions)

Exhibit 22: Key takeaway: Anatomic pathology testing market in UK

Exhibit 23: PEST analysis: Anatomic pathology testing market in UK

Exhibit 24: Market overview: Anatomic pathology testing market in APAC

Exhibit 25: Anatomic pathology testing market in APAC 2016-2021 ($billions)

Exhibit 26: Key takeaway: Anatomic pathology testing market in China

Exhibit 27: PEST analysis: Anatomic pathology testing market in China

Exhibit 28: People in age group 60 years and above worldwide 2010-2050

Exhibit 29: Companies and laboratories focusing on biomarkers

Exhibit 30: Companies focusing on companion diagnostic and personalized medicine

Exhibit 31: Impact of drivers

Exhibit 32: Impact of drivers and challenges

Exhibit 33: Partnership between companies and venture capitalists

Exhibit 34: Business strategies by companies to remain competitive in market

Exhibit 35: Competitive structure analysis of global anatomic pathology testing market 2015

Exhibit 36: Competitive analysis of global anatomic pathology testing market 2016

Exhibit 37: Abbott Diagnostics: Strength assessment

Exhibit 38: Abbott Diagnostics: Strategy assessment

Exhibit 39: Abbott Diagnostics: Opportunity assessment

Exhibit 40: Agilent Technologies: Strength assessment

Exhibit 41: Agilent Technologies: Strategy assessment

Exhibit 42: Agilent Technologies: Opportunity assessment

Exhibit 43: Danaher: Strength assessment

Exhibit 44: Danaher: Strategy assessment

Exhibit 45: Danaher: Opportunity assessment

Exhibit 46: Roche Diagnostics: Strength assessment

Exhibit 47: Roche Diagnostics: Strategy assessment

Exhibit 48: Roche Diagnostics: Opportunity assessment

Exhibit 49: Thermo Fisher Scientific: Strength assessment

Exhibit 50: Thermo Fisher Scientific: Strategy assessment

Exhibit 51: Thermo Fisher Scientific: Opportunity assessment

Exhibit 52: Other prominent vendors